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EnzymeThe kinesin-13 family of microtubule depolymerases is a major regulator of microtubule dynamics.
RNA interference-induced knockdown studies have highlighted their importance in many cell
division processes including spindle assembly and chromosome segregation. Since microtubule
turnovers andmost mitotic events are relatively rapid (in minutes or seconds), developing tools that
offer faster control over protein functions is therefore essential to more effectively interrogate
kinesin-13 activities in living cells. Here, we report the identiﬁcation and characterization of a
selective allosteric kinesin-13 inhibitor, DHTP. Using high resolution microscopy, we show that
DHTP is cell permeable and can modulate microtubule dynamics in cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction the process of cell division. Although RNA interference (RNAi)-Microtubules form the cytoskeletal network that supports the
shapes of different cell types. They are also the core component of
the mitotic apparatus that is assembled to segregate chromosomes
during cell division. Microtubules are intrinsically dynamic, sto-
chastically switching between growth and shrinkage, a phenome-
non called dynamic instability [1]. It is known that the dynamic
properties of microtubules are essential for their functions [2]. In
cells, microtubule polymerization dynamics are precisely regulated
spatially and temporally by stabilizing and destabilizing factors.
The kinesin-13 family of microtubule depolymerases is amajor reg-
ulator of microtubule dynamics [3,4]. Loss of function studies have
shown that kinesin-13 proteins are essential for many mitotic pro-
cesses including spindle assembly, chromosome segregation and
kinetochore-microtubule attachment error correction in multiple
species [5–9]. Therefore, understanding how kinesin-13s regulate
microtubule dynamics in mitosis is fundamental to understandinduced knockdown studies of three human kinesin-13s, Kif2a,
Kif2b and Kif2c (or MCAK, Mitotic Centromere Associated Kinesin)
and of kinesin-13s from other species have highlighted their func-
tional importance and non-redundancy [7,8,10,11], the temporal
resolution of this perturbation method is rather limited because
of the time it takes to deplete the target proteins (in days). Since
microtubule turnover, as well as many cellular processes such as
spindle assembly and chromosome segregation are relatively rapid
(in the time scale of seconds or minutes), developing tools that
allow faster temporal control over protein function is an important
step towards a better understanding of kinesin-13 functions in
living cells. Small molecules are a convenient tool that ﬁts this
criterion, but selective kinesin-13 inhibitors are still lacking.2. Materials and methods
2.1. Materials
2.1.1. Chemicals
All chemicals were purchased from Bioshop except the
following: ATP and GTP (Jena Bioscience), taxol/paclitaxel
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Fig. 1. (A) Chemical structure of DHTP. (B) Dose response curves of kinesin-13-
induced ATPase activity versus increasing concentrations of DHTP used to deter-
mine the IC50 values of MCAK and Kif2a are shown. (C) Inhibition of 20 lM DHTP on
MCAK-induced microtubule depolymerization by sedimentation assay. DMSO
equivalent to the volume of the dissolved DHTP (1% of the reaction volume) was
used as control. A representative coomassie blue-stained gel of the supernatant (S)
and pellet (P) fractions is shown (N > 3). (D) The selectivity of DHTP for kinesin-13
proteins were tested against a panel of motile kinesins at 50 lM in the ATPase
assay. For B and D, each data point represents average value from at least three
independent experiments. Error bars = S.E.M. Values are expressed in percentage
inhibition relative to the corresponding DMSO controls. Corresponding dose
response plots of ATPase rates versus DHTP concentrations and the measured rates
for all kinesins are provided in the Supplementary data (Fig. S2).
2316 L. Talje et al. / FEBS Letters 588 (2014) 2315–2320(LC laboratories), malachite green and ammonium molybdate (MP
biomedicals), perchloric acid (Fisher) and casein (Sigma). DHTP
((Z)-2-(4-((5-(4-chlorophenyl)-6-(isopropoxycarbonyl)-7-methyl-3-oxo-
3,5-dihydro-2H-thiazolo[3,2-a]pyrimidin-2-ylidene)methyl)phenoxy)
acetic acid) was purchased from Specs.
2.1.2. Protein reagents
Tubulins were puriﬁed from bovine brain and modiﬁed using
standard protocols [12]. Kinesin constructs were generated by
amplifying the desired coding regions from plasmids containing
the corresponding cDNAs via Polymerase Chain Reactions (PCR).
All kinesin constructswere expressed in Escherichia coli and puriﬁed
using standard afﬁnity chromatography (Ni–NTA or glutathione).
More detailed information is provided in the Supplementary
material.
2.2. ATPase assay and high-throughput screening
Amalachite green-based phosphate detection assay was used to
screen for small molecule inhibitors of kinesin-13 ATPase activity
and subsequent characterization of DHTP. The general composition
of the ATPase reaction is as follows: BRB40 (40 mM PIPES pH 6.8,
0.5 mM EGTA, 0.5 mM MgCl2), 10 lM taxol, X lM microtubules,
X nM kinesin, X mM KCl, 0.25 mg/ml casein, 1 mM DTT, 1 mM
MgCl2, 0.02% Tween-20 and X mM ATP. Full description of the
exact conditions used in different experiments is detailed in the
Supplementary material.
2.3. Microtubule depolymerization assays
2.3.1. Microtubule sedimentation assay
Microtubule sedimentation assay was done as previously
described [13]. Brieﬂy, kinesin-13-induced reactions comprised of
50–75 nM enzyme, 1 mM ATP and 2 lM microtubules were set
up similarly as those for the ATPase assay. After a 15-min
incubation, reaction mixes were spun at 60–80 K RPM in a Sorvall
S120AT3 rotor for 5 min. Supernatant and pellet fractions were
then resolved by SDS–PAGE and processed as described [13].
2.3.2. Microscopy-based microtubule depolymerization assay
Microscopy-based microtubule depolymerization assay was
done as follows: A ﬂow chamber assay was set up similarly
as described for kinesin-5-driven surface gliding assay using
GST-Eg5(1-437) and X-Rhodamine-labeled GMP-CPP microtubules
[14,15]. To simultaneously initiate Eg5-driven motility and
kinesin-13 induced microtubule depolymerization, reaction mix
containing kinesin-13 (50 nM MCAK-MD or Kif2a-MD, 1X BRB40,
50 mM KCl, 0.5 mg/ml casein, 1 mM MgATP, and 1X oxidation
mix: 22.5 mM glucose, 0.22 mg/ml glucose oxidase (Sigma G-2133),
0.036 mg/ml catalase (Sigma C-40) and 4 mM DTT, was introduced
into the chamber in the presence of either DHTP or DMSO. The
movement and shortening of microtubules were captured by a
time-lapse recording every 15 s using a Zeiss Axio-Imager Z1micro-
scope equipped with a 63  1.4 Plan-APOCHROMAT objective and a
Zeiss AxioCam HRm camera. Recorded images were visualized and
analyzed by kymography using MetaMorph (Molecular Devices).
2.4. Live imaging of microtubule dynamics
Drosophila S2 cells stably expressing tubulin-GFP were cultured
in optical glass-bottom plates (Greiner bio-one) coated with conca-
navalin A (Sigma). Cells were treated with DMSO (vehicle) or with
10 lM DHTP. Images were acquired 15–20 min after treatment.
Live imaging was performed using Deltavision elite microscope
(Applied Precision) in a temperature-controlled environment
(27 C). For each condition at least 6 independent wells weretreated. Images were acquired using a CoolSNAP HQ2 camera
(Photometrics) every 5 s for 5–8 min. Images were processed using
Softworx (Applied Precision), Image J (NIH) and Photoshop (adobe)
software. To determine the microtubule dynamics the tips of indi-
vidual microtubules were tracked manually using Image J package.
A minimum of 56 microtubules and 6 individual cells were tracked
and measured for each condition. For the tracking analysis, a
displacement of less than or equal to 1 pixel (107 nm lateral)
between 2 consecutive time frames (5s) was considered stationary
(=displacement of 0) and therefore a ‘‘pause’’ event. A displace-
ment of more than 1 pixel between 2 consecutive frames was con-
sidered either a shrinkage or a growth depending on its previous
position. Digital traces of microtubule ends were then obtained
by plotting the displacements from the origin (position at t = 0 s)
against time.
3. Results and discussion
To identify small molecule inhibitors of the kinesin-13 family of
microtubule depolymerases, we screened a chemical library of
110000 compounds using an ATPase activity-based assay. The
rationale is based on the fact that kinesin-13s are ATPases and
ATP hydrolysis is required for catalytic depolymerization of
microtubules [16,17]. To achieve this, we used a construct of the
human kinesin-13 protein MCAK (MCAK-MD, minimal domain
residues 187–589) that is competent in both ATP hydrolysis and
L. Talje et al. / FEBS Letters 588 (2014) 2315–2320 2317microtubule depolymerization. We veriﬁed that this MCAK con-
struct was robust with kinetic parameters comparable to those of
the published literature ([17–19] and Fig. S1). We established a
robust malachite-green based phosphate detection ATPase assay
in a 384-well format (with a Z score above 0.7) for the high-
throughput screen (see Supplementary experimental methods).
From the primary screen, we identiﬁed compounds that gave more
than 25% inhibition as candidate hits, which were subsequently
cherry-picked and reconﬁrmed in quadruplicates. We then tested
the conﬁrmed hits with another kinesin-13 construct, Kif2a-
MD(126-527) and against other kinesin motors including kine-
sin-1 and kinesin-5, in order to identify potential kinesin-13 selec-
tive inhibitors. Among the candidate hits, DHTP emerged to be the
most potent compound that inhibited both the ATPase activity and
kinein-13 induced microtubule depolymerization (Fig. 1A–C). We
determined the IC50 of DHTP in inhibiting kinesin-13-induced
microtubule stimulated ATPase activity to be about 4.6 lM for
MCAK and 1.2 lM for Kif2a (Figs. 1B, S2A). In addition, DHTP
showed a drastic inhibition of MCAK-driven microtubule depoly-
merization in a centrifugation-based sedimentation assay which
monitors depolymerization via the separation of the pelleted poly-
mers from the dissociated tubulin dimers in the supernatant
(Fig. 1C). These results prompted us to characterize this compound
further. To assess the selectivity of DHTP against kinesin-13s,
we tested microtubule-stimulated ATPase activity with three
kinesin-13 proteins, MCAK, Kif2a and the Drosophila kinesin-13-
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of competitive inhibition, left) and DHTP (right) are shown. Error bars = S.E.M. (B) Comp
inhibition was obtained with 2 or 10-fold changes in microtubule concentration. Error bar
and microtubule-stimulated ATPase activity of MCAK. Error bars = Standard deviations
obtained from at least 3 experiments.ortholog KLP10A, and against a panel of kinesins from other fami-
lies. We found that DHTP has no signiﬁcant inhibitory effect on
other families of kinesin motors even at 50 lM, a concentration
at which DHTP almost completely blocked kinesin-13 induced
ATPase activity (for both MCAK and Kif2a and to a lesser extent
KLP10A, Figs. 1D, S2B). DHTP differs from other compounds that
have been reported to target kinesin-13s [20,21], in its selectivity
against other kinesins. For example, the thiazole compounds
reported by Rickert et al. also inhibit other kinesins including kine-
sin-5 [20]. The effect of SQAGs (sulfoquinovosylacylglycerols),
another type of compounds reported to target MCAK, on other
kinesins has not been tested [21]. And with their low binding afﬁn-
ity to MCAK (Kd of 60–300 lM), SQAG’s mode of inhibition is in
doubt [21]. In comparison, our data show that DHTP is a potent
and selective inhibitor of kinesin-13 proteins.
To assess the mode of inhibition, we ﬁrst determined whether
DHTP is an ATP competitive inhibitor. We performed ATPase assays
with a 10-fold change in ATP concentration in the presence of
DHTP. The rationale is that for competitive inhibitors, the IC50 will
change with varying ATP concentrations. As an example of
competitive inhibition, we used ADP which binds to the same
nucleotide-binding pocket as ATP does. We found that while a
10-fold increase in ATP concentration from 0.1 mM to 1 mM
resulted in about a 20-fold increase in the IC50 value for ADP, it
did not considerably affect the IC50 value for DHTP (Fig. 2A). When
we measured the MCAK-induced ATPase rates with increasing ATP40
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Fig. 3. (A) An illustration depicting a microscopy-based kinesin-13-driven micro-
tubule depolymerization assay. (B) Three frames of a time-lapsed recording of
microtubule gliding (by Eg5) and depolymerization (by MCAK-MD) in DMSO
control and DHTP are shown. A reference point in the middle of shown microtubule
(arrowhead) is indicated to show the movement and shortening of microtubules.
(C) Corresponding kymographs of the microtubules shown in B. Bar, 5 lm. (D)
Quantiﬁcation on the rates of GST-Eg5(1-437)-driven microtubule gliding and
MCAK-MD-driven depolymerization (from 3 independent experiments, n = 60
microtubules for each condition, error bars = standard deviations).
2318 L. Talje et al. / FEBS Letters 588 (2014) 2315–2320concentrations, we also found that DHTP progressively decreased
the maximal turnover rates (Fig. S3). These results indicate that
DHTP is not an ATP competitive inhibitor. Next we considered
the possibility that DHTP could target microtubules instead of
binding to the enzymes directly. If this is true, increasing the
microtubule concentration should decrease the potency of the
compound. To test this, we varied the microtubule concentrations
from 0.5 lM to 5 lM in the ATPase assay. We found that even a
10-fold increase in microtubule concentration did not decrease
the percentage of inhibition of DHTP at around the IC50 concentra-
tion (5 lM, Fig. 2B), suggesting that DHTP’s inhibition of kinesin-13
ATPase activity is not through binding to microtubules. This assess-
ment is consistent with the observation that DHTP is kinesin-13
selective as evident by its lack of effect on other kinesins
(Fig. 1D). Next we determined whether DHTP can inhibit kinesin-
13 activity in the absence of microtubules. We examined both
the basal activity and tubulin dimer-stimulated activity of MCAK.
We found that DHTP had a much lesser effect on dimer-stimulated
activity, and had no inhibitory effect on the basal activity of MCAK
at a concentration as high as 50 lM (Fig. 2C). Together, these
data show that DHTP inhibits kinesin-13 most potently in the
microtubule-bound state in a manner that is neither ATP- nor
microtubule-competitive.
Although the microtubule sedimentation assay can detect the
effect of DHTP inhibition on kinesin-13 induced microtubule
depolymerization and can be quantitative, it only measures micro-
tubule depolymerization in bulk. To visualize how DHTP affects
MCAK-driven microtubule depolymerization at the single ﬁlament
level, we developed a microscopy-based ﬂow chamber assay to
monitor the progression of depolymerization on individual micro-
tubules. In this assay, ﬂuorescently-labeled microtubules are
anchored on a glass coverslip via surface immobilized GST-Eg5 (a
kinesin-5) in a ﬂow chamber. To initiate microtubule depolymer-
ization, a reaction mix containing kinesin-13 proteins (MCAK-MD
or Kif2a-MD) and ATP was ﬂowed into the chamber. Time lapse
imaging of X-Rhodamine-labeled microtubules showed that both
kinesin-13-induced microtubule shortening and kinesin-5 driven
motility could be readily detected. In the presence of DHTP, we
found that while the rate of MCAK-induced microtubule depoly-
merization was greatly reduced (by 74% at 5 lM and by 89% at
10 lM), Eg5-driven microtubule gliding was unaffected (Fig. 3).
Similar results were obtained for Kif2a (not shown). This shows
the selectivity of DHTP towards kinesin-13 proteins over kinesin-
5, which is consistent with what we observed in the ATPase assay
(Fig. 1D).
It is known that depletion of individual kinesin13s by RNAi-
induced knockdown results in a variety of mitotic defects such as
monopolar spindle formation (for Kif2a or Kif2b) and misaligned
chromosomes (for MCAK) [7,8]. However, there was also a report
of the lack of monopolar spindle phenotype upon Kif2a or Kif2b
knockdown [22]. Being cognizant of this, we treated cultured cells
with DHTP to determine if we could observe any mitotic defects.
Despite our numerous attempts, we did not observe any obvious
phenotypes similar to those observed in individual kinesin-13
knockdowns in HeLa or U2OS cells [7,8] (data not shown). To
account for the lack of mitotic phenotypes, we considered two pos-
sibilities. First, DHTP might not be cell permeable. Second, small
molecule inhibition of kinesin-13 proteins could differ from RNAi-
based knockdown. To distinguish these two possibilities and
because of the controversy of knockdown phenotypes in mamma-
lian cells, we decided to monitor microtubule dynamics directly
upon DHTP treatment in Drosophila S2 cells. We chose S2 cells for
the following reasons. First, DHTP also inhibits the Drosophila kine-
sin-13 protein KLP10A, in addition to human kinesin-13s (Fig. 1D).
Second, it is feasible to monitor polymerization dynamics of indi-
vidual microtubule ﬁlaments in S2 cells, as we and others haveshown [13,23]. Third, KLP10A knockdown phenotypes have been
reported in S2 cells, including the effect on microtubule dynamics
[11]. Based on live cell imaging in S2 cells expressing tubulin-GFP,
we observed that microtubules were in general less dynamic in
DHTP-treated cells, as evident by the increase in time they spent
in pause (neither growing nor shrinking) (Fig. 4), consistent with
what was observed upon KLP10A depletion [11]. In addition, these
microtubules showedmore persistent growth towards the cell edge
and had fewer catastrophes as evident by microtubule end tracking
and dynamic parameter measurements (Fig. 4B and D). Together,
these data show that DHTP is a cell permeable kinesin-13 inhibitor
and can modulate microtubule dynamics in cultured cells.
In summary, we report here the identiﬁcation of a cell perme-
able kinesin-13 selective inhibitor. By treating cells with DHTP,
we observed an outcome consistent with kinesin-13 inhibition –
change in microtubule dynamics. In particular, we showed that
DHTP treatment resulted in more persistent growth of microtu-
bules with decreased frequency of catastrophe in cultured cells
as evident by our analysis of individual microtubules. Currently,
one of the limitations of DHTP is that it inhibits multiple kinesin-
13 proteins (different isoforms and orthologs from other species
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Fig. 4. (A) Time-lapse projection of microtubules in live cell imaging of GFP-tubulin expressing Drosophila S2 cells. Time frames of the GFP channel are overlaid and shown in
heat map (blue to red, 60 frames every 5 s). Bar = 5 lm. The corresponding movies are included in the Supplementary material. (B) Representative traces of displacement of
the microtubules indicated by arrowheads in (a). (C) Quantiﬁcation of percentage of time microtubules spent on pause (neither growing nor shrinking), as a measure of
dynamicity. The plot shows the percentage of time spent by individual microtubules on pause. Boxes show top and bottom quartiles, horizontal bold lines show median
values, and vertical lines show minimal and maximal values. Each dot represents an individual microtubule. P-value = 7.25  1023. (D) Measurements of dynamic
parameters by tracking individual microtubule ends in cells treated with DMSO control and DHTP. State transitions of microtubules are quantiﬁed and shown (G: growth, S:
shrinkage, and P: pause). P-values of <0.05 are shown in red.
L. Talje et al. / FEBS Letters 588 (2014) 2315–2320 2319such as Drosophila KLP10A). In order to examine the roles of indi-
vidual kinesin-13 proteins, it would be essential to develop selec-
tive DHTP analogs targeting each of the three kinesin-13s in
human in the near future. Given the fact that DHTP inhibits both
MCAK and Kif2a, as well as the Drosophila kinesin-13 KLP10A
and that it is not ATP competitive, we postulate that DHTP must
target a common allosteric site among kinesin-13 proteins. One
interesting possibility is the site analogous to the monastrol bind-
ing site on kinesin-5 [24]. This pocket is formed by the loop L5,
which varies considerably among kinesins. Like kinesin-5, kine-
sin-13 has one of the longest L5 loops. Therefore, it is logical to
think that this allosteric pocket is also present in kinesin-13s, as
evident by the crystal structures of MCAK and Kif2a ([25] and
PDB code of KIF2a: 2GRY). Since allosteric sites are in general more
divergent and often under lesser selective pressure than the cata-
lytic pocket, obtaining sub-family selectivity is an achievable goal.
However, as suggested by our data, DHTP may only bind to a
microtubule-bound conformation of kinesin-13 or to a lesser
extent a tubulin dimer-bound conformation. Therefore, it is still
technically challenging to determine exactly how DHTP binds to
the proposed allosteric pocket solely based on the crystal
structures because of the fact that DHTP does not inhibit the basalactivity of both Kif2a and MCAK, and the loop L5 is not resolved in
the aforementioned kinesin-13 crystal structures.
Our discovery of DHTP as a pan-kinesin-13 selective inhibitor
provides the ﬁrst step towards developing sub-family speciﬁc
inhibitors and using them as chemical biology tools to examine
the regulation of microtubule dynamics mediated by kinesin-13
proteins. In addition, since overexpression of kinesin-13 proteins
(MCAK and Kif2a) has been reported in multiple cancer cells and
has been suggested to be a possible cause for resistance to micro-
tubule-targeting drugs such as taxol [26], kinesin-13 inhibitors will
therefore open new possibilities to develop alternative chemother-
apeutics and to overcome some of the drug resistance issues asso-
ciated with tubulin poisons.
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